These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 33548204

  • 1. Hepatobiliary morbidities detected by ultrasonography in Opisthorchis viverrini-infected patients before and after praziquantel treatment: a five-year follow up study.
    Mairiang E, Laha T, Kaewkes S, Loukas A, Bethony J, Brindley PJ, Sripa B.
    Acta Trop; 2021 May; 217():105853. PubMed ID: 33548204
    [Abstract] [Full Text] [Related]

  • 2. Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand.
    Thinkhamrop K, Khuntikeo N, Sithithaworn P, Thinkhamrop W, Wangdi K, Kelly MJ, Suwannatrai AT, Gray DJ.
    Infect Dis Poverty; 2019 Mar 20; 8(1):18. PubMed ID: 30890188
    [Abstract] [Full Text] [Related]

  • 3. Ultrasonography assessment of hepatobiliary abnormalities in 3359 subjects with Opisthorchis viverrini infection in endemic areas of Thailand.
    Mairiang E, Laha T, Bethony JM, Thinkhamrop B, Kaewkes S, Sithithaworn P, Tesana S, Loukas A, Brindley PJ, Sripa B.
    Parasitol Int; 2012 Mar 20; 61(1):208-11. PubMed ID: 21771664
    [Abstract] [Full Text] [Related]

  • 4. Ultrasonographic features of hepatobiliary pathology in opisthorchiasis and opisthorchiasis-associated cholangiocarcinoma.
    Mairiang E.
    Parasitol Int; 2017 Aug 20; 66(4):378-382. PubMed ID: 27956092
    [Abstract] [Full Text] [Related]

  • 5. Persistent advanced periductal fibrosis is associated with cagA-positive Helicobacter pylori infection in post-praziquantel treatment of opisthorchiasis.
    Phung HTT, Deenonpoe R, Suttiprapa S, Mairiang E, Edwards SW, Sripa B.
    Helicobacter; 2022 Aug 20; 27(4):e12897. PubMed ID: 35527695
    [Abstract] [Full Text] [Related]

  • 6. Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis.
    Wangboon C, Yongvanit P, Loilome W, Thanan R, Worasith C, Eamudomkarn C, Chamadol N, Mairiang E, Sithithaworn J, Saichua P, Sripa B, Khuntikeo N, Bethony JM, Sithithaworn P.
    Am J Trop Med Hyg; 2018 Jun 20; 98(6):1763-1769. PubMed ID: 29637887
    [Abstract] [Full Text] [Related]

  • 7. Decreased risk of cholangiocarcinogenesis following repeated cycles of Opisthorchis viverrini infection-praziquantel treatment: Magnetic Resonance Imaging (MRI) and histopathological study in a hamster model.
    Hanpanich P, Laha T, Sripa B, Mairiang E, Sereerak P, Upontain S, Tangkawattana P, Brindley PJ, Tangkawattana S.
    Parasitol Int; 2017 Aug 20; 66(4):464-470. PubMed ID: 27143606
    [Abstract] [Full Text] [Related]

  • 8. Ultrasound screening for Opisthorchis viverrini-associated cholangiocarcinomas: experience in an endemic area.
    Mairiang E, Chaiyakum J, Chamadol N, Laopaiboon V, Srinakarin J, Kunpitaya J, Sriamporn S, Suwanrungruang K, Vatanasapt V.
    Asian Pac J Cancer Prev; 2006 Aug 20; 7(3):431-3. PubMed ID: 17059338
    [Abstract] [Full Text] [Related]

  • 9. Enhanced neutrophil functions during Opisthorchis viverrini infections and correlation with advanced periductal fibrosis.
    Salao K, Spofford EM, Price C, Mairiang E, Suttiprapa S, Wright HL, Sripa B, Edwards SW.
    Int J Parasitol; 2020 Feb 20; 50(2):145-152. PubMed ID: 32006550
    [Abstract] [Full Text] [Related]

  • 10. Re- Infection Rate of Opisthorchis Viverrini Five Years After Treatment with Praziquantel in High-Risk Area: A Community-Based Study.
    Saengsawang P, Buakate P.
    Asian Pac J Cancer Prev; 2024 Aug 01; 25(8):2679-2684. PubMed ID: 39205565
    [Abstract] [Full Text] [Related]

  • 11. Reinfection by Opisthorchis Viverrini after Treatment with Praziquantel.
    Saengsawang P, Promthet S, Bradshaw P.
    Asian Pac J Cancer Prev; 2016 Aug 01; 17(2):857-62. PubMed ID: 26925692
    [Abstract] [Full Text] [Related]

  • 12. Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma.
    Sudsarn P, Boonmars T, Ruangjirachuporn W, Namwat N, Loilome W, Sriraj P, Aukkanimart R, Nadchanan W, Jiraporn S.
    Pathol Oncol Res; 2016 Jan 01; 22(1):57-65. PubMed ID: 26277607
    [Abstract] [Full Text] [Related]

  • 13. Subtle to severe hepatobiliary morbidity in Opisthorchis viverrini endemic settings in southern Laos.
    Ayé Soukhathammavong P, Rajpho V, Phongluxa K, Vonghachack Y, Hattendorf J, Hongvanthong B, Rasaphon O, Sripa B, Akkhavong K, Hatz C, Odermatt P.
    Acta Trop; 2015 Jan 01; 141(Pt B):303-9. PubMed ID: 25275346
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for Opisthorchis viverrini Infection in Nong Khai Province, Thailand.
    Chudthaisong N, Promthet S, Bradshaw P.
    Asian Pac J Cancer Prev; 2015 Jan 01; 16(11):4593-6. PubMed ID: 26107209
    [Abstract] [Full Text] [Related]

  • 15. [Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention].
    Buisson Y.
    Bull Soc Pathol Exot; 2017 Feb 01; 110(1):61-67. PubMed ID: 28105582
    [Abstract] [Full Text] [Related]

  • 16. Infection with Opisthorchis viverrini and use of praziquantel among a working-age population in northeast Thailand.
    Saengsawang P, Promthet S, Bradshaw P.
    Asian Pac J Cancer Prev; 2013 Feb 01; 14(5):2963-6. PubMed ID: 23803062
    [Abstract] [Full Text] [Related]

  • 17. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke Opisthorchis viverrini-Associated Advanced Periductal Fibrosis and Cholangiocarcinoma.
    Surapaitoon A, Suttiprapa S, Mairiang E, Khuntikeo N, Pairojkul C, Bethony J, Brindley PJ, Sripa B.
    Korean J Parasitol; 2017 Jun 01; 55(3):295-304. PubMed ID: 28719954
    [Abstract] [Full Text] [Related]

  • 18. A combination of praziquantel and the traditional medicinal plant Thunbergia laurifolia on Opisthorchis viverrini infection and cholangiocarcinoma in a hamster model.
    Wonkchalee N, Boonmars T, Laummaunwai P, Aromdee C, Hahnvajanawong C, Wu Z, Sriraj P, Aukkanimart R, Chamgramol Y, Pairojkul C, Juasook A, Sudsarn P.
    Parasitol Res; 2013 Dec 01; 112(12):4211-9. PubMed ID: 24057695
    [Abstract] [Full Text] [Related]

  • 19. Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand.
    Haswell-Elkins MR, Mairiang E, Mairiang P, Chaiyakum J, Chamadol N, Loapaiboon V, Sithithaworn P, Elkins DB.
    Int J Cancer; 1994 Nov 15; 59(4):505-9. PubMed ID: 7960220
    [Abstract] [Full Text] [Related]

  • 20. Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos.
    Sripa B, Bethony JM, Sithithaworn P, Kaewkes S, Mairiang E, Loukas A, Mulvenna J, Laha T, Hotez PJ, Brindley PJ.
    Acta Trop; 2011 Sep 15; 120 Suppl 1(Suppl 1):S158-68. PubMed ID: 20655862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.